Blockchain Development for Healthcare Supply Chains: Tracking Drugs and Devices

Navigating Healthcare Supply Chains in a Compliance Crunch

Healthcare supply chains are really dealing with some serious compliance challenges these days. This guide is designed to help decision-makers understand how to make the most of blockchain technology in conjunction with GS1 EPCIS, VRS, and UDI/EUDAMED. By doing that, you'll be all set to tackle those upcoming U.S. You’ve got to keep an eye on those DSCSA and EU MDR/IVDR deadlines, and don’t forget about making sure you have solid tracking for both your drugs and medical devices. It’s a lot to juggle, but staying on top of it all is key!

Here’s the scoop: By linking EPCIS event streams, ATP credentials, and the device UDI master data to a secure ledger (and sharing just the right bits publicly when needed), organizations can prove traceability while keeping their sensitive info safe and sound. This method not only helps to speed up recalls but also makes audits for DSCSA (2025 and beyond) and EUDAMED (kicking off May 28, 2026) a lot easier.

---

Why now: the regulatory clock just advanced

• United States (Drugs and the DSCSA). So, just a heads up--the FDA's "stabilization period" for the DSCSA's improved electronic package-level tracking came to an end on November 27, 2024. No need to stress if you haven't made the full switch just yet! The FDA has actually given some leeway with specific exemptions. So, manufacturers and repackagers have until May 27, 2025, to get things sorted. Wholesale distributors can take their time until August 27, 2025. If you're running a bigger operation with 26 or more staff, you've got until November 27, 2025. And for those small dispensers, you’re good until November 27, 2026. Take a breather--you’ve got some extra time! Hey, just a quick reminder: if you're taking advantage of these exemptions, make sure you're demonstrating that you're moving forward. Plus, be prepared to transition to a fully interoperable system when the time comes! (fda.gov).
• The FDA has dropped its final guidelines that give us a clearer picture of what “enhanced drug distribution security” actually entails. Basically, it boils down to things like verifying product identifiers, tracking stuff down at the package level, and being quick on the draw when it comes to trace and verification requests. (fda.gov). Industry groups like PDG and HDA have put together some handy blueprints and guidelines to tackle exceptions, along with a VRS governance framework. All of this is designed to help trading partners seamlessly get everything up and running in a fully interoperable way. (dscsagovernance.org).

You've got the European Union in the mix, especially when it comes to devices and the regulations like MDR (Medical Device Regulation) and IVDR (In Vitro Diagnostic Regulation). So, here’s some exciting news! On November 27, 2025, the European Commission shared that the first four modules of EUDAMED are officially live and kicking. This kicks off a six-month transition period. Hey there! Just a heads up--by May 28, 2026, you're going to have to get familiar with Actor Registration, UDI/Devices, Notified Bodies & Certificates, and Market Surveillance. It might seem like a lot, but you’ve got this! No need to stress! We'll definitely dive into Vigilance and Clinical Investigations/Performance Studies a bit later on.
Take a look at this for more details: health.ec.europa.eu. It's got all the info you need! Hey, just a quick reminder that the clock is ticking on those UDI label placements! If you’ve got MDR Class I devices, you’ll need to have their labels sorted out by May 26, 2025. So, make sure you’re on top of that! Oh, and don’t forget--if you have any old devices lying around, you’ll want to get them registered by November 27, 2026.
Hey, if you want the latest info, check this out: (webgate.ec.europa.eu). It's got all the details you need!

• Global trendlines
• In the U.S. Hospitals and regulators are really ramping up their efforts with product verification services (VRS) to take a closer look at any products that seem a bit off. Back in January 2025, Arkansas pulled off a pretty impressive feat--they verified a suspect Ozempic lot in just a few days. They did this by using the NABP Pulse PVS. (nabp.pharmacy). So, in India, they made some changes to their export traceability policy in 2025. They decided to drop the export track-and-trace rule from the DGFT. At the same time, they're stepping up their game with barcode usage at home and introducing pharmacy QR codes to make it easier for people to report any adverse drug reactions. This really highlights the mix of global regulations that your systems are going to have to navigate. (economictimes.indiatimes.com).

Here's the deal: Between 2025 and 2026, auditors and regulators are going to be paying a lot of attention to how well everything operates together. They’re really going to be on the lookout for operational interoperability. Blockchain really could be that perfect solution we’ve been looking for--it’s like the friendly glue that keeps everything together. Plus, it does a great job of maintaining the important data systems we need for DSCSA and EUDAMED.

---

What blockchain adds (and what it shouldn’t replace)

Blockchain isn’t trying to take the place of GS1 standards, EPCIS repositories, or regulatory portals. Instead, it’s here to boost them by providing:

You can really count on the reliability of EPCIS events--like commissioning, packing, shipping, receiving, and de-aggregating--thanks to some solid cryptographic anchoring and notarized timelines. We've set up these really cool shared registries that show clear evidence of any tampering for our Authorized Trading Partner (ATP) credentials and relationship attestations. And guess what? They're all powered by OCI verifiable credentials! This means you’ll spend way less time digging through manual license lookups! Take a look here: (oc-i.org). You might find it super helpful! Non-repudiation plays a crucial role in VRS lookups and responses, not to mention when we're dealing with regulators. Just imagine all those trace and verification requests we handle through Pulse or NABP! And hey, we’ve totally got data minimization sorted out! Want to learn more? Check it out at nabp.pharmacy! With selective disclosure, you can definitely prove that you have compliant TI/TS data for a specific lot or serial number, or even show that you met the response time in the Service Level Agreement. And the best part? You can do all of this without compromising any commercial or patient information. Pretty handy, right?

It shouldn't:

• Make sure to keep those EPCIS payloads, PHI, and any commercial terms directly on the chain. Instead of copying the EUDAMED/GUDID master data, it's a better idea to just link hashes and keep track of pointers.

---

Standards you must align with (and how blockchain fits)

• GS1 EPCIS/CBV
• EPCIS 2. 0 is really raising the bar with some cool tech! They’re using JSON/JSON-LD for data handling, REST for pulling and pushing information, and they’ve got sensor telemetry in place to keep an eye on those cold chains. Plus, they’ve incorporated digital link URIs, which are just what you need for today's microservices and IoT environments. It's all pretty impressive! Consider using on-chain anchors for your event batches, like daily Merkle roots. It’s a great way to ensure your traces stay clean and easily auditable. If you're looking for more info, be sure to swing by gs1.org. They’ve got all the details you might need!
• DSCSA Interoperability and VRS.

So, let's chat about the Drug Supply Chain Security Act (DSCSA) and something called VRS, which stands for Verification Router Service. This whole thing is about making sure that prescription drugs are safe and that we can keep track of them as they move through the supply chain. The DSCSA is all about enhancing security and transparency, and VRS plays a key role by helping different systems talk to each other. Pretty cool, right? It’s like giving everyone in the supply chain a way to verify that what they’re dealing with is legitimate. Hey, just a quick reminder to follow PDG's 2023+ Blueprint and those connection templates. They’re super important! When you're putting together your chain services, don’t forget to check out those EPCIS connection details and the exception root-cause taxonomies. They'll really help you out! By doing it this way, your on-chain attestations will match up perfectly with how PDG deals with exceptions. If you’re looking for a more in-depth look, check out dscsagovernance.org. It’s definitely worth a visit! When you're dealing with saleable returns and keeping an eye out for any questionable products, make sure to connect with HDA’s VRS Provider Network. They’ve got your back! Make sure to record your verification claims (you know, the request and response digests) on the blockchain. This way, you’ll have easy access to them later if you need to dig into any details. If you want to learn more, just check out hda.org for all the details!

• ATP credentials for trading partners. Jump on the OCI ATP credentials train and simplify your life by automating license validation with handy services like Legisym! Don't forget to keep track of when you issue or revoke credentials on a permissioned chain. This way, you can easily check trust levels across various systems whenever you need to. If you're curious to dive deeper into this topic, check out the details over at ledgerdomain.com. They’ve got a lot more information that can clarify things for you!
• Device UDI and EUDAMED: So, when we talk about Device UDI, we're really diving into the unique identifiers required for medical devices. It's all about keeping track of them in a standardized way. EUDAMED, on the other hand, is the EU's database that stores information about these devices. It's pretty crucial for making sure everything is up to standard and safe for users.
• It's really crucial to make sure your UDI master data stays consistent across all your source systems and the GUDID/EUDAMED. Make sure you use the ledger to officially record all your device listings, certificate references, and any market surveillance submissions made by economic operators. If you want to dive deeper into the topic, head over to fda.gov for some great info!

---

Reference architectures that work in 2025-2026

1) DSCSA Drug Tracing and Verification

The Drug Supply Chain Security Act, or DSCSA for short, is really focused on ensuring that the medications we take are safe and truly what they say they are. It sets up a countrywide system to track and trace prescription drugs from where they come from all the way to when they hit the pharmacy shelf. Let me give you a quick overview of how it all works:

Key Points of DSCSA

• Serialization: Each package of prescription medication comes with its very own unique identifier. This makes tracking and tracing a breeze!
• Verification: This is all about making sure that the medications pharmacies and healthcare providers are getting are the real deal. Before handing out the medication to patients, they can double-check that the drug is the right one.
• Interoperability: This system makes it super easy for everyone in the supply chain to share data. That way, nobody's left out of the loop, and everyone’s on the same page!
• Reporting Requirements: So, manufacturers and distributors are expected to share certain details to keep everything above board and transparent throughout the supply chain.

Why It's Important

• Patient Safety: DSCSA is super important when it comes to keeping patients safe. By making sure that the drugs are not just effective but also real and safe, it really helps protect people from counterfeit or contaminated medications.
• Regulatory Compliance: It's super important for companies to stick to these rules to steer clear of fines and keep their licenses in good standing.
• Trust in Healthcare: Being more open about things really helps create a stronger bond of trust between patients and their doctors.

If you’re looking for more in-depth info about the DSCSA, definitely take a look at the FDA’s official page. It’s a great resource!

Staying in the loop about these regulations is super important for everyone in the drug supply chain, whether you're a manufacturer or a pharmacist!

• Components Every organization gets their own EPCIS 1. 2/2. 0 repository.
• Connecting with the VRS client and using the Lookup Directory.
• You know, it’s all about getting that ATP credentialing (OCI) sorted out, along with making sure we verify the license.
• We’ve got integration set up with Pulse and NABP, making it super easy to handle regulatory stuff and requests across different networks.
• Imagine a permissioned blockchain setup, like Hyperledger Fabric or an enterprise EVM, that comes with:
• Ways to share proof between two parties (like a manufacturer and a wholesaler).
• Regular public L2 anchoring for independent timestamping.
• Flow (this could be a returnable product or something that might raise some eyebrows). Alright, here’s how it works: First, you scan the GS1 DataMatrix. Then, that information gets sent off to the manufacturer responder through a VRS query. After that, the manufacturer signs their response and sends it back to you. All of this is recorded on-chain, which includes the hash of the request and response, ATP IDs, a timestamp, and some SLA metrics. Plus, to make sure everything lines up just right according to PDG guidelines, there’s an off-chain EPCIS/ASN cross-check to sort out any discrepancies. Cool, right? (hda.org).
• So, what’s the deal with it passing audits? The FDA really values quick verification and accurate product IDs, and that's where your ledger shines. It provides reliable proof of response times and ATP status right as the transaction is happening. (fda.gov).

2) EU Medical Devices UDI/EUDAMED Readiness

Preparing for the new EU regulations on medical devices might seem a bit daunting, but don’t sweat it--we're here to help! Let’s break down what you should know about UDI (Unique Device Identification) and EUDAMED (the European Database on Medical Devices).

What’s UDI all about?

The UDI system is all about simplifying how we keep tabs on medical devices from start to finish. So, each device will come with its own unique code. This little feature is all about keeping things safe, transparent, and accountable in healthcare.

EUDAMED: The Hub for Medical Device Data

EUDAMED is basically a big central database where you'll find all the important details about medical devices. This will really benefit a bunch of different people, like manufacturers, regulators, and healthcare professionals, by making it easier for them to get their hands on important device data.

Getting Prepared

To help you get comfortable in this new situation, here are a few steps you might want to think about:

1. Get to Know the Rules: Take some time to dive into the EU MDR (Medical Device Regulation) and IVDR (In Vitro Diagnostic Regulation). It’s super important to understand what’s required so you’re ready for whatever comes your way!

2. Get Started with UDI: Begin thinking about how to weave UDI into your product labels and packaging. It's a good idea to map out a plan for this! This is really important for making sure we're following the rules.

3. Get Ready for EUDAMED Registration: It's time to start getting your devices ready for registration in EUDAMED!
Keeping an eye on post-market safety is super important.

4. Conduct Training: It’s important to get your team familiar with UDI and EUDAMED requirements. Let’s ensure everyone is on the same page and knows what’s expected! Knowledge is key!.

5. Stay in the Loop: Make sure to stay updated on any changes or updates to these regulations since things can shift over time.

Useful Resources

If you're looking for detailed info on UDI, check out the European Commission's UDI Guidance. It’s super helpful! You can find it right here: European Commission UDI Guidance.

• If you want to explore EUDAMED a bit more, check out the EUDAMED Portal.

If you follow these steps, you won’t just be checking off compliance boxes--you’ll actually help make healthcare a safer place for everyone involved. Keep moving ahead--you’re totally capable of this!

• Components
• We've got the UDI master data management all connected with EUDAMED for UDI/Devices.
• Here are some references for the Notified Body certificate registry.
• At hospitals, they’re using point-of-care scanning with GS1 identifiers to help manage recall processes.
  • Permissioned blockchain for:
• Taking snapshots of device registrations, which basically means capturing the hashes of UDI/DEV records.
• Staying on top of our conversations with regulators, such as noting down market surveillance case IDs.
• You can optionally anchor implant logs to help out registries.
• Flow of UDI Registration and Recall. The manufacturer starts the process by registering the device and then uploads all the necessary information to EUDAMED. After that’s all set, the ledger goes ahead and logs a hash of the record along with the SRN and the certificate reference as soon as you submit it. So, when a Field Safety Corrective Action kicks in, we take a look at the hospital's inventory scans and match them up with the UDI snapshots that are tied to our records. This helps us figure out exactly when notifications were sent out and when items were set aside. Take a look at this: health.ec.europa.eu. You’ll find some important info there!

---

• Verifying Products on a Big Scale. Hey there! Just a quick update: NABP's Pulse PVS, which runs on the MediLedger PVS, is now being used by regulators in more than 20 states across the U.S. How cool is that? You’ve got the states and the DEA field offices. Back in January 2025, different boards started looking into semaglutide, which you might recognize as Ozempic. Thanks to a blockchain layer, those verification transactions can be notarized across various networks. This really helps speed up how quickly disputes get resolved. Take a look at this link: nabp.pharmacy. It’s got some interesting info you might want to check out!
• **EPCIS 2. 0 with Sensor Telemetry for Biologics.
• EPCIS 2. Now, the latest version comes with built-in temperature and humidity tracking, along with support for JSON-LD. Pretty cool, right? We've seen that teams are getting into the groove of grouping their event digests every hour, especially for those chilly shipments that are around -70°C. They’re linking everything up to a Fabric channel and then sharing a daily root to an affordable L2. Pretty smart move! With this setup, investigators can actually have cryptographic proof that the entire cold-chain situation is secure. And the best part? It doesn’t reveal any raw sensor data at all. (gs1.org).
• VRS Governance Alignment The HDA’s VRS Provider Network has built a pretty reliable system for handling request and response messaging, as well as keeping the lookup directory updated. By keeping track of any changes in the lookup directory--such as updates to responder CIs and certificates--right on the blockchain, we can sidestep those annoying “stale directory” problems that tend to arise during audits. If you want to dive deeper into it, just click here for more info!
• The rollout plan for EU EUDAMED. Hey, just a heads up! Based on Decision (EU) 2025/2371, the first four modules are set to become mandatory starting May 28, 2026. That's not too distant, so teams are gearing up with these "EUDAMED proof packs." These packs have everything they need, like SRN evidence and checks to ensure the UDI info is all complete. It’s exciting to see everyone preparing! They're putting all of this onto a consortium ledger to prove that everyone's good to go before those surprise regulator spot checks come knocking. If you're looking for more info, you can check it out here. It's got all the details you need!

---

Best emerging practices we recommend (with specifics)

• Just go with EPCIS 2. Even if your partners are still at level 1.

• Go ahead and use GS1's EPCIS Sandbox to easily switch between different scenarios. 2 and 2. Hey, don't forget to check out those event vocabularies and make sure they're all validated, alright? Make sure to keep your internal repositories at version 2. 0 while sharing 1. 2 with partners who still need to catch up. (gs1.org).

Imagine blockchain as a cool platform where you can manage policies and verify things. It's like a digital space that keeps everything in check!

• Rather than saving payloads, it’s better to hang on to hashes, credentials, and the results of policies. Every time you send out an EPCIS transmission, you’ll want to generate an on-chain attestation. This should cover a few important details: who sent the data (that’s the hash), where it’s headed (the ATP ID), when it all went down, and the reason for the transaction (like the business step and disposition). It’s a straightforward way to keep everything organized and transparent! This means auditors have a reliable, concrete framework to rely on while they do their jobs.
• Go ahead and start using OCI verifiable credentials for those ATP checks! With OCI, you can easily issue and verify ATP credentials. Plus, you can stay on top of the entire credential lifecycle--whether you’re issuing new ones, suspending, or even revoking them--all right on the ledger. That means you can skip the hassle of tracking down emails or digging through screenshots when you're trying to investigate something. Take a look at this link: (oc-i.org). You won't want to miss it!
• Record VRS verifications directly on the blockchain. Make sure to upgrade your VRS client so it can start issuing signed "verification claims." These should include details like the request ID, responder ID, the result, and the response hash. These claims can really help speed things up when it comes to figuring out the root cause during investigations into questionable products or any sort of diversions. (hda.org).
• It's a good idea to whip up those DSCSA exceptions playbooks ahead of time.
• Let's convert those PDG/HDA exception categories--like serial misalignment and aggregation breaks--into smart contract enums. This means we can easily keep tabs on when exceptions come up and when they get resolved, as well as how they stack up against their SLAs. Take a look at it over here: dscsagovernance.org. You might find it really interesting!
• For your devices, make sure to set up a UDI “golden record” along with the necessary ledger proofs. Making sure that the UDI master data is top-notch is super important to the FDA. Just to keep everything straightforward, make sure you hash snapshots of your UDI datasets. This will help track the journey from any engineering changes right through to the submissions for EUDAMED and GUDID. Just a quick reminder--make sure to include the SRN, DI, and PI semantics, along with those certificate references. It's important we have all that in there! If you want to dive deeper into this, check out the details over at fda.gov. It's a great resource!
• Brace yourself--EUDAMED's phased roll-out is coming your way! Hey there! When you get a chance, could you map out what your duties will be for the four required modules that are kicking off in 2026? Also, don’t forget about the two that are coming down the line a bit later. Thanks! It’s a great idea to get your internal “EUDAMED Day-1 Readiness” attestations in place. Just make sure you have your actors registered, all the UDI fields are filled out, and that you’ve uploaded the necessary NB certificates. It’s also a good practice to review everything every quarter to keep things on track. (health.ec.europa.eu).
• Show how the chain of custody works for the cold chain. Make the most of EPCIS sensor extensions to keep an eye on any temperature changes. Let’s make sure we batch this info on-chain every hour for those high-value biologics, and for the smaller molecule products, we can do it once a day. Make sure to use Merkle trees for each lane. This way, we can keep data exposure to a minimum and only share it with those who really need access. (gs1.org).

---

Implementation blueprint (what we deliver in 12-20 weeks)

• Weeks 1-3: Preparing and Designing. Let’s take a closer look at the gap assessment for DSCSA and EUDAMED. We’ll break it down by product family, distribution lane, and the specific market we’re dealing with. Sounds good?
• Create a detailed layout of the event taxonomy for EPCIS 2. 0 and come up with a partner capability matrix that compares 1. 2 with 2. 0). First off, you’ll want to pick your ledger fabric, which means choosing between Fabric or the enterprise EVM. Once you’ve made that decision, figure out how often you want to anchor things.

Alright, so here’s the plan for weeks 4 to 8: we’re gonna put together the “attestation spine.” It’s a pretty important part of the process, so let’s make sure we give it the attention it deserves! First things first, let’s get that permissioned ledger up and running! Once that’s sorted, we can dive into setting up those channels and ACLs to make sure everything’s secure and organized.

• Let's get started on rolling out EPCIS hash anchoring and setting up those smart contracts to verify claims. Get the ATP credentialing set up in OCI, and double-check that the license verification is all sorted out.

Alright, so for weeks 9 to 12, we’re diving into Interop and VRS. Let's fire up the VRS client and get it going! We’ll need to start tracking those verification claims and directory state proofs. Let's kick things off by running a pilot program. We’ll team up with two trading partners and bring in one regulator workflow. We'll use Pulse PVS wherever it makes sense to streamline the process. (pulse.pharmacy).

• Weeks 13-20: Getting Ready for Device/UDI and EUDAMED. Alright, first things first--let's get that UDI golden record hashed. After that, we need to whip up the SRN proof bundle. Oh, and don’t forget to have those Notified Body certificate references ready to go. You know how important they are! Let’s run a mock recall drill to walk through how we can spot and isolate products from beginning to end, all while sticking to our service level agreements. It’ll be a great way to see the process in action! Just a quick reminder to make sure you jot down the results based on the EUDAMED timeline. It's super important! (health.ec.europa.eu).

---

Data model and volume planning (realistic numbers)

• We're talking about a mid-sized pharmaceutical company that sells around 10 million units a year. You can count on seeing about 4 to 6 EPCIS events for each unit as it goes through its various stages, like commissioning, packing, shipping, receiving, and de-aggregation. So, when you do the math, that comes out to around 50 million events annually. Hey! So, instead of putting every single raw event onto the blockchain, it’s a lot smarter to just drop one attestation for a whole batch--let’s say around 10,000 events. You can throw in a Merkle root along with it too! It keeps things cleaner and more efficient. So, what this means is that we’re looking at roughly 5,000 on-chain writes each year for every lane. Honestly, that’s pretty doable, even if you're going with the more cautious Fabric or EVM setups.
• A device manufacturer with around 50,000 different products available across various markets. Every three months, we hash the UDI master records. So, we're expecting to see about 200 to 400 writes on the blockchain every quarter. This covers things like certificate updates and any changes to actor profiles.
• Verification activity So, when we're talking about returns and those tricky checks, you can pretty much count on it being around 0. 3-0. So, about 8% of the inbound cases will actually require VRS. Just go ahead and notarize those! HDA's VRS PN governance ensures that we've got strong request and response semantics set up. Feel free to take a look at it here.

---

Privacy, security, and auditability

• Try not to include any personal health info or pricing details in the conversation. Just a quick reminder: when it comes to DSCSA and UDI flows, you don’t have to worry about including any PHI. So, it’s best to stick with EPCIS, GUDID, EUDAMED, and whatever internal systems you’re using for all that. Keep it simple! It's smart to use specific relationship channels or private data collections to keep sensitive info, like pricing events that involve pharmacies, under wraps. This way, you can keep those details separate and secure. How about considering some optional public anchoring on a budget-friendly Layer 2 solution each day? It's a great way to create independent timestamps while keeping your business info safe and sound.

---

KPIs to prove value beyond compliance

• DSCSA verification response time: We’re shooting for a response rate of at least 99% in under a minute. And just so you know, you can easily verify this through on-chain claims! (fda.gov).
• Mean time to resolution for exceptions: Since we started categorizing PDG and using notarized envelopes, we’ve actually managed to reduce this time by 40%! It's pretty exciting to see those numbers drop. (dscsagovernance.org).
• Device recall timing: Let’s try to cut this down to just a few hours. We can do this by linking point-of-care scans (GS1) with the ledger-backed UDI snapshots. Plus, we’ll coordinate everything with the EUDAMED market surveillance processes to keep things running smoothly. (health.ec.europa.eu).
• Interop coverage: We're doing great and aiming for at least 90% of our partners to be exchanging EPCIS by our target date. 2/2. 0), where we make sure to handle conversion and validation using GS1 tools. (gs1.org).

---

Tooling and vendor ecosystem signals

• EPCIS and Conformance
• GS1 is here to support you with EPCIS 2. 0 Sandbox and some really useful conversion tools. On top of that, quite a few solution providers have grabbed GS1 US EPCIS conformance trustmarks. For instance, TraceLink has racked up an impressive 16 trustmarks covering the entire journey from manufacturers to wholesalers to dispensers. That’s pretty cool, right? Take a look at this link: (gs1.org). You’ll find some cool info there!
• VRS Maturity
  The HDA's VRS Provider Network has got everything you need in terms of governance, lookup directories, and request/response messaging clearly laid out. It's all designed to make things easier for you! Just a heads up: be sure to follow their guidelines closely when you’re implementing things. It'll help you avoid those pesky edge-case failures! Learn more at (hda.org).
• Regulator Networks
  Pulse by NABP is really focused on bringing together regulators and trading partners. They do this using ATP profiles, VRS, and trace workflows, which makes the whole process smoother. You can easily connect using APIs to simplify DSCSA communications and really show that you're all set to go! Check out all the details at pulse.pharmacy! You’ll find some really interesting stuff there.

---

Pitfalls to avoid

Storing payloads on-chain can really cause some serious headaches. You might run into problems with GDPR, intellectual property issues, and scaling difficulties.

• If you skip the exception taxonomy, you're going to run into some issues. Without those PDG/HDA categories in place, it becomes pretty tough to compare how your partners are doing. For more details, be sure to head over to this link: dscsagovernance.org. You’ll find a lot of great info there! So, just to clarify, thinking of blockchain as the main system for traceability isn't entirely accurate. Right now, regulators are primarily looking at EPCIS, UDI, and EUDAMED/GUDID compliance first. Instead, you might want to view blockchain more like an extra layer for auditing or providing assurance. Want to dive into the details? Check it out right here: (fda.gov). You'll get all the info you need! Hey, just a quick reminder not to forget about those device timelines! The first four EUDAMED modules are a must-have starting May 28, 2026. And just a heads up, the vigilance and clinical modules will roll out right after that with no breathing room in between. So, make sure you're ready! It’s definitely a smart move to work on your data model now. It'll save you a ton of hassle down the road when you won’t have to worry about redoing everything! If you’re looking for more details, you can check it out here: health.ec.europa.eu.

---

What great looks like in 2026

Every time a drug transaction happens, there's an EPCIS trail that tags along, complete with a VRS-verifiable product ID. This means we’ve got some solid proof of the who, what, and when for any audits that come our way. Each device comes with its own unique UDI master data, and it’s all kept in sync across various systems like PLM, ERP, and labeling. Plus, you can find it registered in both EUDAMED and GUDID. On top of that, your ledger keeps tabs on when records were created or updated, and it also notes who signed off on them.

• If regulators ever need to check something or trace a transaction, they can grab the info in just a few hours. Plus, your systems provide legitimate proof, not just some static PDFs.

---

How 7Block Labs can help

• DSCSA Accelerator: So, this part features a data model that matches up with the PDG requirements. It also covers the conversion and validation for EPCIS 2, which is pretty handy! So, you’ve got VRS integration, ATP credentialing, and even a ready-to-go Fabric/EVM attestation spine all set up. Pretty cool, right?
• EUDAMED Readiness Kit: Gear up with some cool features! You’ve got the UDI golden record hashing, handy workflows for SRN and actor onboarding, certificate reference anchoring, plus playbooks to help you run recall drills smoothly. It's all about making sure you're prepared!
• Architecture and TCO: Let’s dive into the nitty-gritty of anchoring cadence, how we manage node operations, and the design behind SLAs. We’ll also touch on selective public anchoring and explore the best practices for integrating a zero-trust model.

If you're shooting for full DSCSA compliance by 2025 and want to have those required EUDAMED modules ready by May 28, 2026, then it's definitely time to start moving! Don't wait too long to get the ball rolling.

---

Sources

So, the FDA has set up a stabilization period for the DSCSA, and there are a few exemptions that actually extend past November 27, 2024. You can check out the dates depending on the type of partner you are. Plus, there’s some helpful advice on how to enhance the security and standards for drug distribution! Check it out here.

Hey there! Interested in exploring DSCSA interoperability? The PDG has got your back with a handy Foundational Blueprint. They've even packed it with workshops and templates to help you tackle any exceptions that might pop up. Feel free to check out this resource right here. It's definitely worth a look!

The HDA VRS Provider Network is super important when it comes to verifying saleable returns, so it’s definitely a good idea to take a look at their governance details. You’ll find all the info you need to understand how they operate! Find more info here.

Hey there! So, it looks like regulators are really starting to embrace the NABP Pulse PVS. It’s got some pretty awesome features that make it great for connecting ATP and VRS. Super handy stuff! If you’re interested, you can check it out here.

Hey there! If you're curious about GS1, check out the EPCIS/CBV 2. It's a pretty cool topic to dive into! Hey there! So, there are some cool new features in version 0, plus they’ve rolled out an EPCIS Sandbox and implemented trustmarks for conformance. Exciting stuff! For all the details, check it out here. You won’t want to miss this!

Hey there! Just a heads-up: there's a key EU decision, known as EUDAMED Decision (EU) 2025/2371, that’s going to roll out some mandatory modules starting on May 28, 2026. It’s got all the details on transition timelines and what’s included in those modules. So, mark your calendars! If you're curious to dive deeper into this topic, you can check it out here. Happy reading!

Hey, just a quick reminder to keep an eye on those deadlines for UDI labels. It's super important! Also, here’s a little context about the situation in the U.S. to help you out. Let's talk about the UDI/GUDID program and why it's such a big deal when it comes to data quality. So, the UDI (Unique Device Identification) system is designed to make sure that medical devices are easily trackable and identifiable, which is super important for patient safety. On the flip side, the GUDID (Global Unique Device Identification Database) is where all that device info gets stored.

Now, here's where data quality steps into the spotlight. For the UDI/GUDID program to really work, we need to have top-notch data. If the information is off or incomplete, it can lead to mix-ups, safety issues, and a whole lot of headaches for everyone involved--hospitals, manufacturers, and most importantly, patients.

In short, good data quality isn't just a nice-to-have; it's essential for making this program a success and ensuring that everyone stays safe and informed. So, keeping our data clean and accurate is definitely a priority! Feel free to dive into all the info you need by clicking here.

So, it looks like India is making some interesting policy shifts lately. They're pulling back on the DGFT 2025 and rolling out some updates related to pharmacy ADR QR. It's definitely a time of change! If you want to catch up on the latest news, just click here.

---